ALTSHULER DAVID 1550395 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-11 | 2023-08-09 | 2023-08-09 | 4 | Altshuler David | EVP, GLOBAL RESEARCH AND CSO | dsp | 63.0 | 0.2 | 0.0 | 345.51 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 32038.0 | 258.09 (VRTX) |
| 2023-11-17 | 2023-11-15 | 2023-11-15 | 4 | Altshuler David | EVP, GLOBAL RESEARCH AND CSO | dsp | 19.0 | 0.06 | 0.0 | 369.92 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 32038.0 | 257.68 (VRTX) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 to 2024-02-07 | 4 | Altshuler David | EVP, GLOBAL RESEARCH AND CSO | acq | 20794.0 | 39.36 | 0.81 | 0.0 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code A | 52832.0
|
257.68 (VRTX) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 to 2024-02-12 | 4 | Altshuler David | EVP, GLOBAL RESEARCH AND CSO | dsp | 5244.0 | 9.93 | 0.2 | 421.24 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 47588.0
|
257.68 (VRTX) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 to 2024-02-20 | 4 | Altshuler David | EVP, GLOBAL RESEARCH AND CSO | dsp | 10564.0 | 22.2 | 0.41 | 421.88 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 37024.0
|
258.31 (VRTX) |
| 2024-02-23 | 2024-02-21 | 2024-02-21 | 4 | Altshuler David | EVP, GLOBAL RESEARCH AND CSO | dsp | 3002.0 | 8.11 | 0.12 | 421.77 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code S | 34022.0 | 258.31 (VRTX) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 to 2024-02-26 | 4 | Altshuler David | EVP, GLOBAL RESEARCH AND CSO | dsp | 8209.0 | 24.13 | 0.32 | 428.65 | Direct | Common Stock | VERTEX PHARMACEUTICALS INC / MA | code F S | 25813.0
|
258.31 (VRTX) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)